Mal(Br2)-Aca-OSu is a bioconjugation reagent used in antibody-drug conjugate (ADC) synthesis. It features a dibromo maleimide group and an aminocaproic acid (Aca) linker, terminated with an N-hydroxysuccinimide (OSu) ester. This compound is designed for conjugating antibodies to cytotoxic drugs, with the dibromo maleimide group facilitating selective attachment to thiol groups in the antibody.
Structure of 2389064-41-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.